IDbyDNA Announces Engagement in United States Defense Advanced Research Projects Agency (DARPA) Program to Detect Threats using Gene Editing Technologies

Share Article

Leader in Clinical Metagenomics Collaborates with MRIGlobal, Mammoth Biosciences, Draper, UCSF, and Toolbox Medical Innovations

News Image
"Now more than ever, the world — and particularly, the Department of Defense (DoD) — is in need of innovative solutions that can better identify pathogens and mitigate the spread of disease and other health threats."

Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown, is announcing its participation in the “Detect It with Gene Editing Technologies” (DIGET) program funded by the United States Defense Advanced Research Projects Agency (DARPA). Working in collaboration with MRIGlobal, Mammoth Biosciences, Draper, University of California-San Francisco and Toolbox Medical Innovations, IDbyDNA will leverage its proprietary pathogen database and algorithms to advance DARPA’s goal of providing diagnostic and biosurveillance solutions that detect infectious disease threats, anytime, anywhere.

“Now more than ever, the world — and particularly, the Department of Defense (DoD) — is in need of innovative solutions that can better identify pathogens and mitigate the spread of disease and other health threats,” said Dr. Guochun Liao, founder and CEO of IDbyDNA. “This program will integrate our innovative technology in an effort to leapfrog current approaches to pathogen detection and better support biosurveillance labs globally. IDbyDNA will continue to seek out opportunities to partner with the public sector to leverage clinical metagenomics for the advancement of better diagnostic solutions.”

The DARPA funding will expand the data feeds that IDbyDNA’s Explify® Platform can analyze, including the signals from CRISPR-based assays, in addition to its current NGS applications to support overall threat readiness and promote stabilization missions.

For more information about IDbyDNA and its approach, visit http://www.idbydna.com.

About IDbyDNA
IDbyDNA is revolutionizing the use of clinical metagenomics to improve health by decoding the unknown. IDbyDNA’s product suite delivers unparalleled data analytics and industry-leading expertise to support medical laboratories with actionable infectious disease testing and pathogen surveillance. By profiling tens of thousands of microorganisms from any specimen with a scalable and intuitive approach, IDbyDNA empowers healthcare providers with greater depth and transparency for better identification of pathogens in order to accelerate triage and treatment and improve public health. For more information, visit http://www.idbydna.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eichelberger
Superior PR
3129521528
Email >
Visit website